Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management

References

• Levy JH, Szlam F, Tanaka KA, et al. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg. 2012;114(2):261–274. doi:10.1213/ANE.0b013e31822e1853.
   PubMed Web of Science ®Google Scholar
• Sørensen B, Larsen OH, Rea CJ, et al. Fibrinogen as a hemostatic agent. Semin Thromb Hemost. 2012;38(3):268–273. doi:10.1055/s-0032-1309287.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. Hereditary fibrinogen abnormalities. In: Lichtman MA, Beutler E, et al., editors. Williams Haematology. New York, NY: McGraw-Hill; 2005. p. 1909–1927.
   Google Scholar
• de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009;35(4):356–366. doi:10.1055/s-0029-1225758.
   PubMed Web of Science ®Google Scholar
• Orphanet classification of rare hematological diseases. Paris: Orphanet, the portal for rare diseases and orphan drugs, 2016. [cited 2016 Apr 9] Available from: http://www.orpha.net/consor/cgi-bin/Disease_Classif.php?lng=EN&data_id=194&PatId=3331&search=Disease_Classif_Simple&new=1
   Google Scholar
• Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia. 2004;10(5):593–628.
   PubMed Web of Science ®Google Scholar
• Afibrinogenemia, congenital. Baltimore: Online Mendelian Inheritance in Man, 2014. [cited 2016 Apr 9] Available from: http://omim.org/entry/202400?search=afibrinogenaemia&highlight=afibrinogenaemia
   Google Scholar
• Rabe F, Salomon E. Ueber-faserstoffmangel im Blute bei einem Fallevon Hämophilie. Arch Int Med. 1920;95:2–14.
   Google Scholar
• Hammarsten O. Über die Bedeutung der löslichen Kalksalze bei der Faserstoffgerinnung. Z Physiol Chem. 1896;22:333–395.
   Google Scholar
• Kazal LA. Coagulation chemistry. In: Spiegel HE, editor. Clinical biochemistry. Contemporary theories and techniques. Nutley, NY: Academic Press; 1982. p. 73–144.
   Google Scholar
• Neerman-Arbez M, Honsberger A, Antonarakis SE, et al. Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia. J Clin Invest. 1999;103(2):215–218.
   PubMedGoogle Scholar
• Neerman-Arbez M, Vu D, Abu-sLibdeh B, et al. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood. 2003;101(9):3492– 3494.
   PubMed Web of Science ®Google Scholar
• Stang LJ, Mitchell LG. Fibrinogen. Methods Mol Biol. 2013;992:181–192. doi:10.1007/978-1-62703-339-8_14.
   PubMedGoogle Scholar
• Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:11–30.
   PubMed Web of Science ®Google Scholar
• Neerman-Arbez M, de Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations. Hum Mutat. 2007;28(6):540–553.
   PubMed Web of Science ®Google Scholar
• de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39:585–595.
   PubMed Web of Science ®Google Scholar
• Fibrinogen Assays. Cambridge: Practical-Haemostasis.com, 2013. [cited 2016 Apr 9] Available from: http://www.practical-haemostasis.com/Screening%20Tests/fibrinogen.html
   Google Scholar
• Kant JA, Fornace AJ Jr, Saxe D, et al. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci U S A. 1985;82:2344–2348.
   PubMed Web of Science ®Google Scholar
• Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121(10):1712–1719. doi:10.1182/blood-2012-09-306639.
   PubMed Web of Science ®Google Scholar
• Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304–326. doi:10.1111/bjh.13058.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol. 1992;29(3):177–188.
   PubMedGoogle Scholar
• Fibrinogen Studies Collaboration, Danesh J, Lewington S, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Jama 2005;294(14):1799–1809.
   PubMed Web of Science ®Google Scholar
• Peters SA, Woodward M, Rumley A, et al. Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart health extended cohort. Br J Haematol. 2013;162(3):392–399. doi:10.1111/bjh.12389.
   PubMed Web of Science ®Google Scholar
• Sørensen B, Tang M, Larsen OH, et al. The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res. 2011;128(Suppl 1):S13–S16. doi:10.1016/S0049-3848(12)70004-X.
   Google Scholar
• Congenital fibrinogen deficiency. Paris: Orphanet, the portal for rare diseases and orphan drugs, 2016. [cited 2016 Apr 9] Available from: http://www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&Expert=335
   Google Scholar
• Peyvandi F, Di Michele D, Bolton-Maggs PH, et al. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost. 2012;10(9):1938–1943. doi:10.1111/j.1538-7836.2012.04844.x.
   PubMed Web of Science ®Google Scholar
• Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia. 2008;14(6):1151–1158. doi:10.1111/j.1365-2516.2008.01831.x.
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104(5):1243–1252.
   PubMed Web of Science ®Google Scholar
• Lak M, Keihani M, Elahi F, et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol. 1999;107(1):204–206.
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Vakalopoulou S, Perifanis V, et al. Treatment of congenital fibrinogen deficiency: overview and recent findings. Vasc Health Risk Manag. 2009;5:843–848.
   PubMedGoogle Scholar
• Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost. 2006;4(10):2115–2129.
   PubMed Web of Science ®Google Scholar
• Asselta R, Platé M, Robusto M, et al. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency. Thromb Haemost. 2015;113(3):567–576. doi:10.1160/TH14-07-0629.
   PubMed Web of Science ®Google Scholar
• Chen XC, Xu MT, Zhou W, et al. A meta-analysis of beta-fibrinogen gene-455G/A polymorphism and plasma fibrinogen level in Chinese cerebral infarction patients. Biomed Environ Sci. 2007;20(5):366–372.
   PubMed Web of Science ®Google Scholar
• Casini A, Lukowski S, Quintard VL, et al. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations. Thromb Res. 2014;133(5):868–874. doi:10.1016/j.thromres.2014.01.022.
   PubMed Web of Science ®Google Scholar
• Stanciakova L, Simurda T, Stasko J, et al. Novel fibrinogen bbeta chain mutation as an underlying mechanism of afibrinogenemia? Semin Thromb Hemost. 2015;41(8):901–902. doi:10.1055/s-0035-1564802.
   PubMed Web of Science ®Google Scholar
• World Federation of Hemophilia. Report on the annual global survey 2014. Québec: World Federation of Hemophilia, 2015. [cited 2016 Apr 10] Available from: http://www1.wfh.org/publications/files/pdf-1627.pdf
   Google Scholar
• Patra S, Reddy B, Nagesh CM, et al. Recurrent myocardial infarction in a case of congenital afibrinogenaemia. Heart Views. 2014;15(1):16–18. doi:10.4103/1995-705X.132141.
   PubMedGoogle Scholar
• Y AK, Yaman Y, Isguder R, et al. Spontaneous epidural and subdural haematoma in a child with afibrinogenaemia and postoperative management. Blood Coagul Fibrinolysis. 2014;25(4):398–400. doi:10.1097/MBC.0000000000000049.
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost. 1999;82(4):1207–1214.
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Asselta R, Mannucci PM. Autosomal recessive deficiencies of coagulation factors. Rev Clin Exp Hematol. 2001;5:369–388.
   PubMedGoogle Scholar
• Girolami A, Ruzzon E, Tezza F, et al. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia. 2006;12:345–351.
   PubMed Web of Science ®Google Scholar
• Dupuy E, Soria C, Molho P, et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res. 2001;102(3):211–219.
   PubMed Web of Science ®Google Scholar
• Al-Mondhiry H, Ehmann WC. Congenital afibrinogenaemia. Am J Haematol. 1994;46:343–347.
   PubMed Web of Science ®Google Scholar
• Acharya SS, Coughlin A, Dimichele D, MNorth American Rare Bleeding Disorder Study Group. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004;2:248–256.
   PubMed Web of Science ®Google Scholar
• Ehmann WC, Al-Mondhiry H. Congenital afibrinogenemia and splenic rupture. Am J Med. 1994;96:92–94.
   PubMed Web of Science ®Google Scholar
• Vakalopoulou S, Rizopoulou D, Zafiriadou E, et al. Management of acute bleeding in a patient with congenital afibrinogenaemia. Haemophilia. 2006;12(6):676–678.
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Haertel S, Knaub S, et al. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenaemia or hypofibrinogenaemia. J Thromb Haemost. 2006;4(7):1634–1637.
   PubMed Web of Science ®Google Scholar
• Roqué H, Stephenson C, Lee MJ, et al. Pregnancy-related thrombosis in a woman with congenital afibrinogenaemia: a report of two successful pregnancies. Am J Haematol. 2004;76(3):267–270.
   PubMed Web of Science ®Google Scholar
• Koussi A, Economou M, Athanasiou-Metaxa M. Intra-abdominal haemorrhage due to a ruptured corpus luteum cyst in a girl with congenital afibrinogenaemia. Eur J Pediatr. 2001;160(3):196.
   PubMed Web of Science ®Google Scholar
• Castaman G, Ruggeri M, Rodeghiero F. Congenital afibrinogenaemia: successful prevention of recurrent haemoperitoneum during ovulation by oral contraceptive. Am J Haematol. 1995;49(4):363–364.
   PubMed Web of Science ®Google Scholar
• Bottini E, Pareti FI, Mari D, et al. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenaemia. Case Rep Haematol. 1991;76(5):431–433.
   Google Scholar
• Schneider D, Bukovsky I, Kaufman S, et al. Severe ovarian hemorrhage in congenital afibrinogenaemia. Acta Obstet Gynecol Scand. 1981;60(4):431.
   PubMed Web of Science ®Google Scholar
• Kinebuchi A, Ohtsuka T, Ishida S, et al. Leg ulcer presenting in a patient with congenital afibrinogenaemia. Eur J Dermatol. 2002;12(1):70–72.
   PubMed Web of Science ®Google Scholar
• Rupec RA, Kind P, Ruzicka T. Cutaneous manifestations of congenital afibrinogenaemia. Br J Dermatol. 1996;134(3):548–550.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Surgical wound healing in bleeding disorders. Haemophilia. 2012;18(4):487–490.
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of rare bleeding disorders. J Thromb Haemost. 2012;10(4):615–621. doi:10.1111/j.1538-7836.2012.04653.x.
   PubMed Web of Science ®Google Scholar
• Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost. 2013;39(6):684–692. doi:10.1055/s-0033-1353391.
   PubMed Web of Science ®Google Scholar
• Kumar N, Padma Kumar R, Ramesh B, et al. Afibrinogenaemia: a rare cause of young myocardial infarct. Singapore Med J. 2008;49(4):e104– e106.
   Google Scholar
• Sartori MT, Milan M, de Bon E, et al. Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature. Haemophilia. 2015;21(1):88–94. doi:10.1111/hae.12507.
   PubMed Web of Science ®Google Scholar
• Fuchs RJ, Levin J, Tadel M, et al. Perioperative coagulation management in a patient with afibrinogenaemia undergoing liver transplantation. Liver Transpl. 2007;13(5):752–756.
   PubMed Web of Science ®Google Scholar
• Oruc N, Tokat Y, Killi R, et al. Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication. Dig Dis Sci. 2006;51(2):378–380.
   PubMed Web of Science ®Google Scholar
• Lebreton A, Casini A, Alhayek R, et al. Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis. Haemophilia. 2015;21(1):e108–e110. doi:10.1111/hae.12584.
   PubMed Web of Science ®Google Scholar
• de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost. 2010;36(1):7–17.
   PubMed Web of Science ®Google Scholar
• Grandone E, Tiscia G, Cappucci F, et al. Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management. Haemophilia. 2012;18(1):e16–e18. doi:10.1111/j.1365-2516.2011.02656.x.
   Google Scholar
• Chevalier Y, Dargaud Y, Argaud L, et al. Successive bleeding and thrombotic complications in a patient with afibrinogenaemia: a case report. Thromb Res. 2011;128(3):296–298.
   PubMed Web of Science ®Google Scholar
• Ruiz-Sáez A. Thrombosis in rare bleeding disorders. Haematology. 2012;17(Suppl 1):S156–S158.
   Google Scholar
• De Marco L, Girolami A, Zimmerman TS, et al. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenaemia. J Clin Invest. 1986;77(4):1272–1277.
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Reininger CB, Spannagl M, et al. Effect of fibrinogen substitution in afibrinogenaemia on hemorheology and platelet function. Thromb Haemost. 1995;74(3):853–858.
   PubMed Web of Science ®Google Scholar
• Soria J, Soria C, Borg JY, et al. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology. Br J Haematol. 1985;60(3):503–514.
   PubMed Web of Science ®Google Scholar
• Miesbach W, Schenk J, Alesci S, et al. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenaemia. Thromb Res. 2010;126(6):e428–e433. doi:10.1016/j.thromres.2010.09.004.
   Google Scholar
• Mackie IJ, Kitchen S, Machin SJ, et al. Haemostasis and thrombosis task force of the British committee for standards in haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003;121(3):396–404.
   PubMed Web of Science ®Google Scholar
• Négrier C, Rothschild C, Goudemand J, et al. Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate. J Thromb Haemost. 2008;6(9):1494– 1499. doi:10.1111/j.1538-7836.2008.03076.x.
   PubMed Web of Science ®Google Scholar
• Peyvandi F. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency. Thromb Res. 2009;124(Suppl 2):S9–S11. doi:10.1016/S0049-3848(09)70158-6.
   PubMed Web of Science ®Google Scholar
• Kreuz W, Meili E, Peter-Salonen K, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci. 2005;32:239–246.
   PubMed Web of Science ®Google Scholar
• Simurda T, Stanciakova L, Stasko J, et al. Yes or no for secondary prophylaxis in afibrinogenemia? Blood Coagul Fibrinolysis. 2015;26(8):978–980. doi:10.1097/MBC.0000000000000392.
   PubMed Web of Science ®Google Scholar
• Riastap 1g. West Sussex: EMC, 2014. [cited 2016 Apr 10] Available from: http://www.medicines.org.uk/emc/medicine/24163/SPC/Riastap+1g
   Google Scholar
• Kalina U, Stöhr HA, Bickhard H, et al. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis. 2008;19(8):777–783. doi:10.1097/MBC.0b013e32830ef90c.
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Dimichele D, Castaman G, et al. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost. 2009;7(12):2064–2069. doi:10.1111/j.1538-7836.2009.03633.x.
   PubMed Web of Science ®Google Scholar
• Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med. 2008;18(3):151–157. doi:10.1111/j.1365-3148.2008.00854.x.
   PubMed Web of Science ®Google Scholar
• Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders A United Kingdom Haemophilia Center Doctors’ Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Haemophilia. 2008;14(4):671–684.
   PubMed Web of Science ®Google Scholar
• Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus. 2012;10(1):23–27. doi:10.2450/2011.0015-11.
   PubMed Web of Science ®Google Scholar
• Poon MC. Cryoprecipitate: uses and alternatives. Transfus Med Rev. 1993;7(3):180–192.
   PubMedGoogle Scholar
• Bevan DH. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? Thromb Res. 2009;124(Suppl.2):S12–S16.
   Google Scholar
• Burnouf T, Goubran HA, Radosevich M, et al. Preparation and viral inactivation of cryoprecipitate in blood banks in resource-limited countries. ISBT Sci Ser. 2007;2:121–128.
   Google Scholar
• Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol. 2010;149:834–843.
   PubMed Web of Science ®Google Scholar
• Kreuz W, Meili E, Peter-Salonen K, et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci. 2005;32:247–253.
   PubMed Web of Science ®Google Scholar
• Bornikova L, Peyvandi F, Allen G, et al. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011;9(9):1687–1704. doi:10.1111/j.1538-7836.2011.04424.x.
   PubMed Web of Science ®Google Scholar
• Rizk DE, Kumar RM. Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive. Am J Hematol. 1996;52(3):237–238.
   PubMed Web of Science ®Google Scholar
• Schuepbach RA, Meili EO, Schneider E, et al. Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thromb Haemost. 2004;91(5):1044–1046.
   PubMed Web of Science ®Google Scholar
• Aygören-Pürsün E, Martinez Saguer I, Rusicke E, et al. Retrochorionic haematoma in congenital afibrinogenaemia: resolution with fibrinogen concentrate infusions. Am J Haematol. 2007;82(4):317–320.
   PubMed Web of Science ®Google Scholar
• Henselmans JM, Meijer K, Haaxma R, et al. Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options. Stroke. 1999;30(11):2479–2482.
   PubMed Web of Science ®Google Scholar
• Parameswaran R, Dickinson JP, de Lord S, et al. Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy. Haemophilia. 2000;6(6):705–708.
   PubMed Web of Science ®Google Scholar
• Castaman G. Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders. Blood Transfus. 2008;6(Suppl 2):s39–s44.
   Google Scholar
• Neerman-Arbez M. Molecular basis of fibrinogen deficiency. Pathophysiol Haemost Thromb. 2006;35:187–198.
   PubMedGoogle Scholar
• Neerman-Arbez M, de Moerloose P, Bridel C, et al. Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia. Blood. 2000;96(1):149–152.
   PubMed Web of Science ®Google Scholar
• Neerman-Arbez M. The molecular basis of inherited afibrinogenaemia. Thromb Haemost. 2001;86(1):154–163.
   PubMed Web of Science ®Google Scholar
• Cunningham MT, Brandt JT, Laposata M, et al. Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med. 2002;126(4):499–505.
   PubMed Web of Science ®Google Scholar
• Vu D, Neerman-Arbez M. Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins. J Thromb Haemost. 2007;5(Suppl 1):125–131.
   PubMedGoogle Scholar